Viking Global Investors LP Celldex Therapeutics, Inc. Transaction History

Viking Global Investors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$20.5 - $37.33 $10.1 Million - $18.3 Million	491,207 Added 26.6%	2,337,854 $63 Million
Q1 2022 May 16, 2022	BUY	$27.64 - $39.32 $30.1 Million - $42.8 Million	1,088,766 Added 143.66%	1,846,647 $62.9 Million
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $157,527 - $248,432	-4,415 Reduced 0.58%	757,881 $29.3 Million
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $22.1 Million - $42.7 Million	762,296 New	762,296 $41.2 Million

195

70.7M

218K

310K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.11B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

Stay updated on Viking Global Investors LP with notifications on news.